• Nucleix Secures $55 Million Funding Led by RA Capital Management and Additional Prominent Life Science Investors to Advance Lung EpiCheck® for Early Detection of Lung Cancer

    5 days ago - By San Diego Biotechnology

    SAN DIEGO & REHOVOT, Israel--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, has secured $55 million from a syndicate of leading life science investors in an oversubscribed financing round. The round was led by RA Capital Management, with participation from new investors including funds...
    Read more ...